A little over a year ago, I wrote an article expressing my opinion about the drug donanemab; at that time it was being promoted as a “BREAKTHROUGH” in Alzheimer’s research, but the scientific data did not support such expectations. Today, Lecanemab (Leqembi) has been approved by the European Commission to treat early‑stage Alzheimer’s disease. However, … Continue reading Lecanemab and Beyond: Shifting from Pharma Hype to Real Neuroprotective Care
Tag: vida
New Year, New Brain
A Chance for Renewal Maintaining the consistency needed to sustain certain habits has always been a challenge, and it will continue to be. Interestingly, this difficulty tends to increase the more important those habits are for our well-being trust me, I know! In moments like these, it’s easy to give in to the temptation of … Continue reading New Year, New Brain
Dr. Jonathan A. Cortés Silva 